How to leverage ChatGPT and NLP and text mining capabilities in combination with knowledge graphs. 

Our customer is a leading, global pharmaceutical company that is committed to delivering innovative medicines to improve patient outcomes. They are heavily focused on oncology.

Omics data are an important resource for biopharmaceutical companies. Join ONTOFORCE,  and ZS Associates, as we detail how you can optimize your multi-omics research.

Merck Group is maximizing the value of their vast datasets from across departments using DISQOVER. 

Our customer is a multinational science and technology company that provides patients with innovative medicines and technologies within multiple therapeutic areas.

This panel discussion from BioTechX 2022 with experts from Janssen, Roche, UK Biobank, and Novo Nordisk covers data-centric approaches.

In this webinar, you'll hear from Paul Vauterin CIO of Aelin Therapeutics and James Longden, Head of Discovery Biology at E-therapeutics.

Hear from Daryna Smyrnova, IT Lead at UCB. UCB has been using DISQOVER for over two years to connect and link data sources, and visualize data insights in a user-friendly manner via intuitive dashboards.

How biomarkers serve drug development decisions in pharmacological and medical product development.

Our customer is an American pharmaceutical company focused on developing treatments and technologies for rare diseases and conditions.

Evaluating clinical trials can be cumbersome and time-consuming. Learn from industry experts how this process can be streamlined.

Drive business growth and accelerate digital transformation by applying FAIR principles.

How to locate matching experts in specific domains via study, projects, patents, and by experience?

Pioneering their way on how to comply most efficiently, Merck will share a sneak peek into their strategy to meet IDMP standards. 

How having access to the right market and competitive data helps win the race.

How a new approach to data management can boost efficiency and lead to better decision-making in drug development.

Advanced data integration - the answer for an efficient omics data journey.

Discover our in-depth resources on how to comply with EMA's IDMP regulations.

Explore the new era of life science data research and overcome challenges in data-driven decision-making.

Quickly gain insight into biomarkers associated with specific diseases, their correlation with molecular pathways, and how relevant they are for you. 

Learn how the right clinical data empowers your organization to drive innovation and speed up cycle times.

Thanks to DISQOVER's customizable user interface, the platform is able to be tailored to each user group at LUMC, making it more impactful for both users and data providers when compared to previous tools.

Accessing the correct information is key in clinical development: from trial design hypothesis validation to portfolio management. 

Learn how to have easier and faster access to the correct data to make your IDMP submission.

For viable clinical trials, finding the right people to participate in testing a new drug or treatment is crucial. 

Improve annotation of omics data by advanced data integration for an efficient omics data journey.

Clinical study design and clinical trials are all about spotting the right opportunities at the right time.

How to create an integrated chemical research workflow.

Facilitate compound and molecule property research in early drug discovery with semantic search.

With DISQOVER, we have created a solution that can identify potential new targets for disease treatment.

Find, assemble, and curate evidence faster enhance productivity and get a leg up on your competition.

Learn how DISQOVER locates subject matter experts and key opinion leaders to involve in research studies and clinical trials.

Powered by an intuitive user interface, DISQOVER lets you explore data from disparate sources to uncover new insights in a matter of minutes.

Learn how to unify patient-related data and prepare it for linking with public data sources.

Learn how to speed up the identification process and be the first to the market.

Being able to stay tuned about what’s happening in clinical trials is important in decision-making. Learn how.